ADESHWAR.BO (Adeshwar Meditex BSE) up 12.00% pre-market 30 Jan 2026: key levels ahead
The ADESHWAR.BO stock surged in pre-market trading on 30 Jan 2026, rising 12.00% to INR 21.00 as buyers reacted to higher intraday demand. This move makes Adeshwar Meditex Limited (ADESHWAR.BO) one of the top gainers on the BSE in the pre-market session in India. Volume is slightly above average at 6,000.00 shares versus an average of 4,819.00, signalling follow-through interest. We outline why the jump matters, how the healthcare sector context shapes the move, and what price and valuation levels traders should watch next
Price action and market stats for ADESHWAR.BO stock
Adeshwar Meditex (ADESHWAR.BO) opened pre-market at INR 21.00, up 12.00% from the previous close of INR 18.75. The intraday range is narrow today with both day low and day high at INR 21.00, reflecting an early block trade or limit orders. Market cap stands at INR 303,059,946.00 and shares outstanding are 14,431,426.00, so even modest volume can swing price materially.
Fundamentals and valuation: ADESHWAR.BO stock analysis
On fundamentals Adeshwar posts EPS 1.31 and a trailing PE 16.03, below the Healthcare sector average PE of 38.14, which can signal relative value. Book value per share is INR 25.93, and price to book is 0.72, indicating the stock trades below reported equity per share. Margins are thin—net margin about 2.55%—so valuation should be read alongside cash conversion and receivables cycles.
Technical snapshot and short-term momentum for ADESHWAR.BO stock
Technicals show mixed momentum: RSI is 36.67 and ADX is 43.32, pointing to a strong trend but room for mean reversion. Bollinger middle band is INR 16.73, signalling the current price is above recent averages and volatility (ATR 0.56) is moderate. Traders should watch INR 17.10 (50-day avg) and INR 17.60 (200-day avg) as support zones on pullbacks.
Meyka AI rates ADESHWAR.BO with a score out of 100
Meyka AI rates ADESHWAR.BO with a score out of 100 at 62.83 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The score balances a low price-to-sales (0.43) and healthy current ratio (2.65) against weak receivables turnover and long cash conversion cycle.
Meyka AI’s forecast model projects downside scenarios and timeframes
Meyka AI’s forecast model projects a monthly target of INR 14.71, a quarterly target of INR 12.82, and a yearly target of INR 10.45 versus the current INR 21.00. That implies model-based moves of -29.95% (monthly), -38.95% (quarterly) and -50.25% (yearly). Forecasts are model-based projections and not guarantees; they reflect historical patterns, liquidity, and company fundamentals.
Sector context, risks and trading strategy for ADESHWAR.BO stock
Adeshwar operates in Healthcare — Medical Specialties — where large-cap peers trade at much higher multiples, so ADESHWAR.BO can attract value-seeking flows but remains exposed to demand cycles. Key risks are long days sales outstanding (200.92) and thin free cash flow yield (3.96%). For traders, consider scaled entries with stops under INR 17.10 and short-term targets near the year high INR 25.00, while investors should weigh balance-sheet cycles and receivables recovery.
Final Thoughts
The top-gainer move in the pre-market session puts ADESHWAR.BO stock in focus, but the underlying picture is mixed. Price at INR 21.00 reflects positive short-term demand and a low market cap of INR 303,059,946.00, yet fundamentals show thin margins and long receivables with days sales outstanding near 200.92. Meyka AI’s grade (62.83 /100, Grade B, Suggestion: HOLD) highlights relative value versus sector peers but flags operational friction. Our scenario targets: a near-term tactical target of INR 25.00 if momentum holds, and a model-based downside yearly projection of INR 10.45 (implied -50.25%). Use tight risk control, favour scaled positions for trading, and consult detailed filings before longer-term buys. Meyka AI, as an AI-powered market analysis platform, provides these metrics to aid research; forecasts are model-based projections and not guarantees.
FAQs
Why did ADESHWAR.BO stock jump in pre-market on 30 Jan 2026?
The stock rose 12.00% to INR 21.00 on higher pre-market buying and above-average volume (6,000.00). Moves likely reflect short-covering or block orders; no scheduled earnings were listed for the day.
What valuation metrics matter for ADESHWAR.BO analysis?
Key metrics: PE 16.03, EPS 1.31, PB 0.72, and price-to-sales 0.43. Compare these to Healthcare peers and check receivables and cash conversion for operational risk.
What is Meyka AI’s short-term forecast for ADESHWAR.BO stock?
Meyka AI’s forecast model projects a monthly level of INR 14.71 and a quarterly level of INR 12.82. These are model outputs and not guarantees; they suggest downside pressure absent fresh catalysts.
What trading strategy suits ADESHWAR.BO stock now?
For traders: consider scaled entries, place stop-losses under INR 17.10 (50-day average support), and target INR 25.00 on momentum. For investors, prioritise balance-sheet improvement before adding exposure.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
